Hashimoto Thyroiditis

Θυρεοειδίτιδα Hashimoto - Χασιμότο


Precision Medicine

The most innovative therapeutic approach for Hashimoto’s Thyroiditis

IATOR, relying on advanced medical practices, implements cutting-edge Precision Medicine therapeutic approaches for the prevention and treatment of Hashimoto’s Thyroiditis, an autoimmune disease that has been experiencing a steadily increasing statistical rise in recent decades.

  • Implementation of high-precision diagnostic examinations.
  • Identification of predisposition to Hashimoto’s onset.
  • Detection of the authentic underlying causes of the disease.
  • Application of advanced personalized medical treatment protocols, meticulously adapted to the unique needs of each individual organism.
  • Systematic regulation of the thyroid gland to attain optimal functional levels.
  • Comprehensive restoration of all organism systems.
  • Remarkable enhancement in overall quality of life.


At IATOR, utilizing refined Genetic, Genomic, and Metabolic Analyses, we discern an individual’s susceptibility to later manifest Hashimoto’s, while also meticulously identifying the exact etiology of the disease in those already afflicted.

Via meticulously tailored medical interventions, we attain precise prevention and efficacious treatment, diverging from conventional therapeutic approaches centered around the administration of pharmaceuticals and synthetic thyroid hormones for the management of Hashimoto’s symptoms.

A multifaceted and individually tailored treatment is meticulously crafted, stemming from a strategic design, and:

Enhances immune functionality

Facilitates the suppression or inactivity of genes bearing deleterious information, while promoting the sustained activity of those harboring protective information.

Restores cellular biochemical balance and hormonal equilibrium to optimal levels.

Encompasses a personalized dietary program that addresses individuals’ nutritional requirements, considering their metabolic and genetic peculiarities (Precision Nutrition).

Thoroughly reinstates the functionality of all physiological systems, yielding sustained and concurrent results over the long term.


The sophisticated personalized medical treatment protocols, systematically administered by IATOR with remarkable efficacy, are designed to optimize therapeutic outcomes.

Devoid of pharmaceuticals, exclusive diets, and abstemious measures.

Tailored therapeutic regimens, devoid of chemical residuals and derivatives.

Interventions that operate individually or in synergy, without accompanying side effects.


Read more

Hashimoto’s Thyroiditis – What is it

Hashimoto’s Thyroiditis is an autoimmune disease, characterized by the development of autoantibodies (anti-thyroid antibodies Anti-TPO and Anti-Tg) against the Thyroid Gland. It is also known as chronic lymphocytic thyroiditis.

This ailment is multifactorial and predominantly impacts the female demographic, owing to their distinct metabolic profile and the myriad hormonal fluctuations experienced throughout their lifespan, particularly during the menopausal phase.

A highly distressing event, such as the death of a relative, in an individual genetically predisposed to the expression of the disease, can trigger the onset of autoimmune Hashimoto’s thyroiditis.


Hashimoto – Symptoms

The cardinal manifestation in Hashimoto’s Thyroiditis is the swelling of the Thyroid Gland. This goiter evolves gradually, often accompanied by nodules on the thyroid. The goiter exhibits a moderate size, presenting an irregular surface, a nodular consistency, and a semi-firm texture.

The patient may not be aware of the goiter if it does not reach considerable dimensions. The same applies to nodules. The gland is typically uniformly enlarged, but there may also be asymmetric swelling, taking the form of a large nodule or goiter, due to the predominance of pathological processes in a specific area of the thyroid.

Hashimoto’s Thyroiditis also induces symptoms associated with Hypothyroidism, such as fatigue, drowsiness, memory impairment, dry skin, weight gain, menstrual irregularities, difficulty losing weight, chills, dizziness, palpitations, tachycardia, a sense of suffocation, nervousness, etc.


Hashimoto’s Thyroiditis and Hormones T3, T4, TSH

The gland’s destruction precipitates a decline in serum levels of T3 and T4 thyroid hormones, accompanied by an elevation in TSH hormone. Initially, TSH typically sustains adequate hormonal synthesis through the stimulation of thyroid enlargement, fostering the production of thyroid hormones. However, the gland frequently becomes progressively hypoactive, culminating in hypothyroidism, with or without goiter.


Autoimmune Hashimoto’s Thyroiditis & Gut

The substantial presence of 80-85% of our immune system within the gastrointestinal tract underscores the pivotal role of intestinal function as a primary factor in Autoimmune Diseases, including Hashimoto’s disease.

A healthy gastrointestinal system effectively prevents undigested food particles, microbes, toxins, and other unwanted substances from entering the body through the bloodstream.

The destruction of epithelial cells in the intestinal wall allows substances to enter the body, triggering an immune system response that leads to inflammation. This inflammatory process can occur in various parts of the body. In the case of Hashimoto’s Thyroiditis, the target is the thyroid gland.


Hashimoto and Diet

One of the primary concerns for individuals with thyroid dysfunction is weight management. In individuals with hypothyroidism, the decrease in metabolic rate is often associated with a frequently observed increase in body weight. Furthermore, it has been noted that 90% of individuals with hypothyroidism exhibit high cholesterol levels.

Certain nutritional components can play a beneficial role in alleviating symptoms of Hashimoto’s disease and should be included in the daily diet of patients, while others should be avoided.

Foods that promote the proper function of the thyroid include those containing vitamin D (salmon, sardines, mushrooms, egg yolk), magnesium (spinach, arugula, lettuce, almonds, and pumpkin seeds), selenium (tuna, whole grain bread, lentils), zinc, as well as foods rich in vitamin A (liver, olive oil, and fatty fish).

Indeed, scientific evidence supports the notion that the intake of coffee can significantly improve the function of the thyroid gland, contributing effectively to the alleviation of symptoms related to Hashimoto’s disease.

On the other hand, it is recommended to limit iodine intake. Iodine contributes to the synthesis of T4 and T3. Primary sources of iodine include Himalayan salt and certain fish (cod, haddock, tuna, squid).

On the other hand, it is recommended to limit iodine intake. Iodine contributes to the synthesis of T4 and T3. Primary sources of iodine include Himalayan salt and certain fish (cod, haddock, tuna, squid).




Heindal JJ, Endocrine disruptors and the obesity epidemic, Toxicol Sci 76; 2:247-49, 2003

Baillie  and Hamilton PF, Chemical toxins: a hypothesis to explain the global obesity epidemic, Jalt Complement Med 8 ; 2:185-92, 2002

Alonso-Magdalena P, et al, The estrogenic effect of bisphenol A disrupts pancreatic B-cell function in vivo and induces insulin resistance, Environ Health Perspect 114:106-12, 2006

The Hundred Year Diet in the Wall Street (May 10, 2010, A I5)

Vom Saal FS, Welshons WV, Large effects from small exposures. II. The importance of positive controls in low-dose research on bisphenol A, Environ Res, 100;1:50-76, Jan. 2006

Feige JN, et al, The endocrine disruptor monoethyl-hexyl phthalate is a selective peroxisome proliferator-activated receptor gamma modulator that promotes adipogenesis, JBiol Chem 282:19152-66, 2007

Hatch EE, et al., Association of urinary phthalate metabolite concentrations with a body mass index and waist circumference: a cross-sectional study of NHANES data, 1999-2002, Environ Health 7:27, 2008

Altschul R, Hoffer A. The effect of nicotinic acid on hypercholesterolaemia.

Can Med Assoc J 1960; 82: 783-5. Bandmann O, Vaughan J, Holmans P, et al. Association of slow acetylator genotype for Nacetyltransferase 2 with familial Parkinson’s disease. Lancet 1997;350:1136-1139.

Berge KG, Canner PL. Coronary drug project: experience with niacin. Coronary Drug Project Research Group. Eur J Clin Pharmacol 1991; 40 Suppl 1: S49-51.

Birjmohun RS, Hutten BA, Kastelein JJ, Stroes ES. Efficacy and safety of high-density lipoprotein cholesterol-increasing compounds: a meta-analysis of randomized controlled trials. J Am Coll Cardiol 2005; 45: 185-97.

Biro S, Masuda A, Kihara T, and Tei C. Clinical implications of thermal therapy in lifestyle-related diseases. Exp Biol Med (Maywood). 2003 Nov; 228(10):1245-9.